Late Clinical Valve Thrombosis After Transcatheter Aortic Valve Replacement Despite Non-Vitamin K Anticoagulant

Autor:	Edgard A. Prihadi, Tom Carmeliet, Paul Vermeersch
Přispěvatelé:	Cardiology, Intensive Care, Clinical sciences
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	medicine.medical_specialty Valve thrombosis Transcatheter aortic AF atrial fibrillation medicine.drug_class medicine.medical_treatment heart failure ate clinical leaflet thrombosis Case Report Vitamin k Valve replacement Clinical Case Internal medicine Atrial Fibrillation medicine anticoagulation non-vitamin K anticoagulant therapy OAC oral anticoagulation Antithrombotic therapy Percutaneous aortic valve replacement TAVR transcatheter aortic valve replacement business.industry Anticoagulant INR international normalized ratio TEE transesophageal echocardiography Thrombosis VKA vitamin K antagonist AF medicine.disease Transcatheter aortic valve replacement percutaneous aortic valve replacement MDCT multidetector computed tomography TTE transthoracic echocardiography Heart failure Cardiology cardiovascular system LVEF left ventricular ejection faction DOAC direct oral anticoagulants business Cardiology and Cardiovascular Medicine
Zdroj:	JACC Case Reports
Popis:	This study presents the case of a late clinical leaflet thrombosis 1.5 years after percutaneous aortic valve replacement, despite adequate non-vitamin K anticoagulant therapy. Optimal antithrombotic therapy after transcatheter aortic valve replacement remains undetermined. After switching to vitamin K antagonist therapy, complete resolution occurred at 3 months follow-up. (Level of Difficulty: Intermediate.) Central Illustration
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0fe23bbc0f18d89c0ed82fe47d1359 https://hdl.handle.net/20.500.14017/f71a40f5-475d-49fb-b4ea-05fd06269375 Zobrazit plný text záznamu